You are here

  • Home
  • Archive
  • Volume 102, Issue Suppl 2
  • P191 Evaluation of minimum residual disease in paediatric patients with acute lymphoblastic leukaemia in terms of individualised therapy and prognosis

Article info

Article menu
Download PDFPDF
Posters
P191 Evaluation of minimum residual disease in paediatric patients with acute lymphoblastic leukaemia in terms of individualised therapy and prognosis

Authors

Citation

Serbanica A, Radu L, Zaharia C, et al
P191 Evaluation of minimum residual disease in paediatric patients with acute lymphoblastic leukaemia in terms of individualised therapy and prognosis
Archives of Disease in Childhood 2017;102:A107-A108.

Publication history

  • First published June 6, 2017.
Online issue publication 
November 30, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions